Available in Pharma Franchise/ PCD Pharma Franchise and Third Party Manufacturing.
The Combination of Rabeprazole and Levosulpiride is marketed by Zyrab-L by Aelida Healthcare. Zyrab-L Also available in Third Party Manufacturer.
Rabeprazole and Levosulpiride composition is used for the treatment of Gastric acidity, Frequent persistent heartburn, Mental disorder, Gastroesophageal reflux disease, Irritable bowel syndrome, Depression and other conditions.
Rabeprazole is a Proton Pump Inhibitor and reduces the gastric acid release from the stomach walls.
Levosulpride belong to the class of antipsychotic medicines. However, it is primarily used for its gut motility properties i.e to improve food movement and treats disorders of the stomach and intestines.